Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders
US7439243B2 · kind B2 · utility
5Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2004 |
| Grant date | Oct 21, 2008 |
| Priority date | — |
| Expiry date | May 19, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.